NCT00237159View on ClinicalTrials.gov

Effect of Zoledronic Acid in Patients With Prostate Cancer and Bone Metastasis

PHASE4CompletedINTERVENTIONAL
Enrollment

284

Participants

Timeline

Start Date

October 31, 2002

Primary Completion Date

December 31, 2005

Conditions
Prostate Cancer Patients With Bone Metastasis
Interventions
DRUG

Zoledronic acid

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY